Drug Profile
IPT 803
Alternative Names: IPT-803Latest Information Update: 23 Jun 2020
Price :
$50
*
At a glance
- Originator Tools4Patient
- Class Antiparkinsonians
- Mechanism of Action Dopamine modulators; Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II Parkinson's disease
Most Recent Events
- 17 Jun 2020 Tools4Patient completes a phase I/II trial in Parkinson's disease in USA, Belgium and France (NCT03407378)
- 26 Jun 2018 Phase-I/II clinical trials in Parkinson's disease (Adjunctive treatment) in France, USA and Belgium (unspecified route) (NCT03407378)
- 30 Jan 2018 Tools4Patient plans a phase I/II trial for Parkinson's disease (Adjunctive treatment) in USA and Belgium (NCT03407378)